Literature DB >> 18174850

Increased arousal in a patient with anoxic brain injury after administration of zolpidem.

Sara I Cohen1, Thao T Duong.   

Abstract

A 35-yr-old man sustained an anoxic brain injury resulting from cardiac arrest, with subsequent extreme lethargy and lack of response to stimuli. The patient's lethargy was unresponsive to trials of several medications in attempts to increase arousal. Administration of twice-daily zolpidem 8 mos after injury resulted in a dramatic increase in the level of alertness, including improved speech and gait. When the patient was not able to receive zolpidem for a brief period, the patient's lethargy returned, and he became bedbound until the medication was resumed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18174850     DOI: 10.1097/PHM.0b013e318161971b

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN: 0894-9115            Impact factor:   2.159


  15 in total

Review 1.  Pharmacotherapy for disorders of consciousness: are 'awakening' drugs really a possibility?

Authors:  Rosella Ciurleo; Placido Bramanti; Rocco Salvatore Calabrò
Journal:  Drugs       Date:  2013-11       Impact factor: 9.546

Review 2.  The Effectiveness of Zolpidem for the Treatment of Disorders of Consciousness.

Authors:  Calvin Tucker; Kirsten Sandhu
Journal:  Neurocrit Care       Date:  2016-06       Impact factor: 3.210

Review 3.  Recovery of consciousness after brain injury: a mesocircuit hypothesis.

Authors:  Nicholas D Schiff
Journal:  Trends Neurosci       Date:  2009-12-01       Impact factor: 13.837

Review 4.  Zolpidem-induced sleepwalking, sleep related eating disorder, and sleep-driving: fluorine-18-flourodeoxyglucose positron emission tomography analysis, and a literature review of other unexpected clinical effects of zolpidem.

Authors:  Romy Hoque; Andrew L Chesson
Journal:  J Clin Sleep Med       Date:  2009-10-15       Impact factor: 4.062

Review 5.  Disorders of consciousness after acquired brain injury: the state of the science.

Authors:  Joseph T Giacino; Joseph J Fins; Steven Laureys; Nicholas D Schiff
Journal:  Nat Rev Neurol       Date:  2014-01-28       Impact factor: 42.937

6.  Rehabilitation of spatial neglect.

Authors:  Alonso R Riestra; A M Barrett
Journal:  Handb Clin Neurol       Date:  2013

7.  Effect of zolpidem in chronic disorders of consciousness: a prospective open-label study.

Authors:  Marie Thonnard; Olivia Gosseries; Athena Demertzi; Zulay Lugo; Audrey Vanhaudenhuyse; Marie-Aurélie Bruno; Camille Chatelle; Aurore Thibaut; Vanessa Charland-Verville; Dina Habbal; Caroline Schnakers; Steven Laureys
Journal:  Funct Neurol       Date:  2013 Oct-Dec

8.  Common resting brain dynamics indicate a possible mechanism underlying zolpidem response in severe brain injury.

Authors:  Shawniqua T Williams; Mary M Conte; Andrew M Goldfine; Quentin Noirhomme; Olivia Gosseries; Marie Thonnard; Bradley Beattie; Jennifer Hersh; Douglas I Katz; Jonathan D Victor; Steven Laureys; Nicholas D Schiff
Journal:  Elife       Date:  2013-11-19       Impact factor: 8.140

9.  Trial of Zolpidem, Eszopiclone, and Other GABA Agonists in a Patient with Progressive Supranuclear Palsy.

Authors:  Andrew Young Chang; Erica Weirich
Journal:  Case Rep Med       Date:  2014-09-16

10.  A Retrospective Analysis on Clinical Practice-Based Approaches Using Zolpidem and Lorazepam in Disorders of Consciousness.

Authors:  Bei Zhang; Katherine O'Brien; William Won; Sheng Li
Journal:  Brain Sci       Date:  2021-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.